CBGL (Cannabis Global) Net Current Asset Value: $-0.02 (As of May. 2022)


What is Cannabis Global Net Current Asset Value?

Cannabis Global CBGL Net Current Asset Value is $-0.02 as of May. 2022.

In calculating the Net Current Asset Value (NCAV), Benjamin Graham means a company's current assets (such as cash, marketable securities, and inventories) minus its total liabilities (including preferred stock, minority interest, and long-term debt).

Cannabis Global's net current asset value per share for the quarter that ended in May. 2022 was $-0.02.

The historical rank and industry rank for Cannabis Global's Net Current Asset Value or its related term are showing as below:

CBGL's Price-to-Net-Current-Asset-Value is not ranked *
in the Drug Manufacturers industry.
Industry Median: 5.32
* Ranked among companies with meaningful Price-to-Net-Current-Asset-Value only.

Cannabis Global  (OTCPK:CBGL) Net Current Asset Value Explanation

Benjamin Graham first discussed net current asset value (NCAV) in the 1934 edition of "Security Analysis", which he coauthored with David Dodd. In the book, (net) current asset value is defined as:" current assets alone, minus all liabilities and claims ahead of the issue."

The common definition of NCAV is: NCAV = current assets – [total liabilities + minority interest + preferred stock]

Net current assets exclude not only the intangible assets but also the fixed and miscellaneous assets. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.

One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham’s strategy produced similar results.

Benjamin Graham looked for companies whose market values were less than two-thirds of their Net-Net Working Capital. They are collected under our Net-Net screener.


Cannabis Global Net Current Asset Value Related Terms


Cannabis Global Net Current Asset Value Historical Data

* Premium members only.

The historical data trend for Cannabis Global's Net Current Asset Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cannabis Global Net Current Asset Value Chart

Cannabis Global Annual Data
Trend Aug12 Aug13 Aug14 Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21
Net Current Asset Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.02 -0.01 0.00 -0.14 -0.15

Cannabis Global Quarterly Data
Aug17 Nov17 Feb18 May18 Aug18 Nov18 Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22
Net Current Asset Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.15 -0.15 -0.05 -0.02 -0.02

CBGL vs MILC, BBBT, GCAN: Net Current Asset Value Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Cannabis Global's Price-to-Net-Current-Asset-Value, along with its competitors' market caps and Price-to-Net-Current-Asset-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cannabis Global Price-to-Net-Current-Asset-Value vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cannabis Global's Price-to-Net-Current-Asset-Value distribution charts can be found below:

* The bar in red indicates where Cannabis Global's Price-to-Net-Current-Asset-Value falls into.



Cannabis Global Net Current Asset Value Calculation

Cannabis Global's Net Current Asset Value (NCAV) per share for the fiscal year that ended in Aug. 2021 is calculated as

Net Current Asset Value Per Share(A: Aug. 2021 )
=(Total Current Assets-Total Liabilities-Minority Interest-Preferred Stock)/Shares Outstanding (EOP)
=(0.442-9.983-3.568-0.001)/84.940
=-0.15

Cannabis Global's Net Current Asset Value (NCAV) per share for the quarter that ended in May. 2022 is calculated as

Net Current Asset Value Per Share(Q: May. 2022 )
=(Total Current Assets-Total Liabilities-Minority Interest-Preferred Stock)/Shares Outstanding (EOP)
=(1.297-7.287-4.408-0.001)/553.143
=-0.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Net Current Asset Value of $-0.02 mean?
Cannabis Global (CBGL) has a Net Current Asset Value of $-0.02 as of May. 2022. Ben Graham's net current asset value equals the per-share value of total current assets less total liabilities. View historical data on Cannabis Global and its competitors.
Is Cannabis Global's Net Current Asset Value too high?
Cannabis Global's current Net Current Asset Value is $-0.02.
How does Cannabis Global's Net Current Asset Value compare to MILC and BBBT?
Cannabis Global's Net Current Asset Value of $-0.02 can be compared against companies in the Drug Manufacturers industry. The industry median Net Current Asset Value is 5.32. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Current Asset Value for a Drug Manufacturers company?
The median Net Current Asset Value among Drug Manufacturers companies is 5.32, based on 612 companies in the industry. Companies in the top quartile (top 25%) have a Net Current Asset Value significantly above this median, while those in the bottom quartile fall well below. However, Net Current Asset Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Current Asset Value mean?
A high Net Current Asset Value can signal that a stock is expensive relative to its fundamentals. Ben Graham's net current asset value equals the per-share value of total current assets less total liabilities. View historical data on Cannabis Global and its competitors. For the Drug Manufacturers industry, the median Net Current Asset Value is 5.32 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cannabis Global's current Net Current Asset Value is $-0.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cannabis Global stock overvalued right now?
Cannabis Global (CBGL) has a current Net Current Asset Value of $-0.02. The current Net Current Asset Value is $-0.02. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Current Asset Value calculated?
Net Current Asset Value is calculated from a company's financial statements. For Cannabis Global (CBGL), the current Net Current Asset Value is $-0.02 as of May. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cannabis Global Business Description

Address 520 S Grand Avenue, Suite 320, Los Angeles, CA, USA, 90071
Cannabis Global Inc manufactures and distributes various cannabis products via its majority ownership of Natural Plant Extract, Inc is developing the Ethos Comply Bag, and generally conducts research and development in the areas of hemp, cannabis and consumer food goods. The company also have an active research and development program focused on creating and commercializing engineered technologies that deliver hemp extracts and cannabinoids to the human body. Its product includes cannabis flower packaged in various weights, cannabis Pre-rolls, cannabis edible products.